Cargando…
Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood
This study investigates the impact of the age at which HIV was acquired on adherence. There was no difference in adherence between patients who acquired HIV in childhood vs. those who acquired it in adolescence/early adulthood (83% vs. 90%; p = 0.24), but achievement of virological/immunological eff...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503311/ https://www.ncbi.nlm.nih.gov/pubmed/36143175 http://dx.doi.org/10.3390/jpm12091390 |
_version_ | 1784795932092530688 |
---|---|
author | Marcellin, Anthony Martel-Laferrière, Valérie Genest, Anne-Geneviève Lebouché, Bertrand Marcotte, Suzanne |
author_facet | Marcellin, Anthony Martel-Laferrière, Valérie Genest, Anne-Geneviève Lebouché, Bertrand Marcotte, Suzanne |
author_sort | Marcellin, Anthony |
collection | PubMed |
description | This study investigates the impact of the age at which HIV was acquired on adherence. There was no difference in adherence between patients who acquired HIV in childhood vs. those who acquired it in adolescence/early adulthood (83% vs. 90%; p = 0.24), but achievement of virological/immunological efficacy (78.8% vs. 93.5%, p = 0.02) was less likely in patients who had acquired HIV in childhood. On the basis of resistance, patients who acquired HIV in adolescence/early adulthood tended to be more eligible for cabotegravir/rilpivirine treatment (90.3% vs. 80.3%; p = 0.11). |
format | Online Article Text |
id | pubmed-9503311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95033112022-09-24 Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood Marcellin, Anthony Martel-Laferrière, Valérie Genest, Anne-Geneviève Lebouché, Bertrand Marcotte, Suzanne J Pers Med Article This study investigates the impact of the age at which HIV was acquired on adherence. There was no difference in adherence between patients who acquired HIV in childhood vs. those who acquired it in adolescence/early adulthood (83% vs. 90%; p = 0.24), but achievement of virological/immunological efficacy (78.8% vs. 93.5%, p = 0.02) was less likely in patients who had acquired HIV in childhood. On the basis of resistance, patients who acquired HIV in adolescence/early adulthood tended to be more eligible for cabotegravir/rilpivirine treatment (90.3% vs. 80.3%; p = 0.11). MDPI 2022-08-27 /pmc/articles/PMC9503311/ /pubmed/36143175 http://dx.doi.org/10.3390/jpm12091390 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Marcellin, Anthony Martel-Laferrière, Valérie Genest, Anne-Geneviève Lebouché, Bertrand Marcotte, Suzanne Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood |
title | Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood |
title_full | Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood |
title_fullStr | Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood |
title_full_unstemmed | Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood |
title_short | Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood |
title_sort | differences in antiretroviral adherence behaviors, treatment success, and eligibility for long-acting injectable treatment between patients who acquired hiv in childhood vs. those who acquired it in adolescence/early adulthood |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503311/ https://www.ncbi.nlm.nih.gov/pubmed/36143175 http://dx.doi.org/10.3390/jpm12091390 |
work_keys_str_mv | AT marcellinanthony differencesinantiretroviraladherencebehaviorstreatmentsuccessandeligibilityforlongactinginjectabletreatmentbetweenpatientswhoacquiredhivinchildhoodvsthosewhoacquireditinadolescenceearlyadulthood AT martellaferrierevalerie differencesinantiretroviraladherencebehaviorstreatmentsuccessandeligibilityforlongactinginjectabletreatmentbetweenpatientswhoacquiredhivinchildhoodvsthosewhoacquireditinadolescenceearlyadulthood AT genestannegenevieve differencesinantiretroviraladherencebehaviorstreatmentsuccessandeligibilityforlongactinginjectabletreatmentbetweenpatientswhoacquiredhivinchildhoodvsthosewhoacquireditinadolescenceearlyadulthood AT lebouchebertrand differencesinantiretroviraladherencebehaviorstreatmentsuccessandeligibilityforlongactinginjectabletreatmentbetweenpatientswhoacquiredhivinchildhoodvsthosewhoacquireditinadolescenceearlyadulthood AT marcottesuzanne differencesinantiretroviraladherencebehaviorstreatmentsuccessandeligibilityforlongactinginjectabletreatmentbetweenpatientswhoacquiredhivinchildhoodvsthosewhoacquireditinadolescenceearlyadulthood |